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Abstract
Obesity, a major social and health problem in many countries, is due to the accumulation
of  white  adipose  tissue  in  subcutaneous  and  visceral  depots.  The  discovery  of
adipocytes capacity of synthesis of numerous adipocytokines and growth factors and
the cross talk between adipocytes and cells of the adipose stromo-vascular fraction had
highlighted the role of adipose tissue dysfunction in obesity. In visceral obesity the
unbalanced synthesis of pro- and anti-inflammatory adipocytokines contributes to the
development of the metabolic syndrome which cumulates the factors that increase the
risk for ischemic heart disease and cerebral stroke. Adipose tissue accumulation is
associated with a state of chronic inflammation, and local hypoxia is considered its
underlying cause due to the hypertrophic or/and the hyperplasic growth of the fat pad.
Adipose tissue hypoxia is one of the first pathophysiological changes and was placed
as a missing link between obesity and low-grade inflammation present in the metabolic
syndrome. Hypoxia is a major trigger for adipose tissue remodeling including adipocyte
death, inflammation, tissue fibrosis, and angiogenesis. Recently, the role of hypoxia in
brown adipose tissue dysfunction, a tissue presumed as the biologic counterbalance of
the metabolic disturbances in human obesity, is discussed.
Keywords: adipose tissue, hypoxia, inflammation, metabolic syndrome, fibrosis, an-
giogenesis
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1. Introduction
Until two decades ago, the adipose tissue has been considered one of the least dynamic structures
of the mammalian organism involved exclusively in fat storage. Some key events have changed
this mechanistic point of view, and now the whole fat of an organism is viewed as a complex
organ composed of at least two main varieties of adipose tissues: the white adipose tissue (WAT)
containing unilocular adipocytes and the brown adipose tissue (BAT) formed by multilocular
adipocytes. Besides this different type of adipocytes, both tissues contain a non-adipocitary
stromo-vascular  fraction  that  includes  undifferentiated  cells,  preadipocytes,  fibroblasts,
inflammatory cells, and various amounts of vessels and nerves. The adult adipose organ is
divided into two types of depots: subcutaneous/peripheral and visceral/central constituted of
lobules of unilocular adipocytes sustained by the stromo-vascular fraction well vascularized
and innervated [1–5].
A significant development in the knowledge of adipose tissue is related to its function as an
endocrine organ, both types of tissues being able to elaborate adipocytokines, humoral factors
with various metabolic, vascular, pro-inflammatory, and anti-inflammatory roles [2, 4].
The accumulation of WAT in physiological depots leads to obesity characterized by an increase
of the body mass index (BMI) over 30 kg/m2 [6]. Obesity became a major social and health
problem in many countries (between one quarter and one third of the population), a recent
report of the World Health Organization (WHO) mentioning more than 1.9 billion of adult
overweight subjects worldwide, more than 600 millions being obese [7]. From a pathogenically
point of view, the quality and the distribution of adipose tissue seem to be more important in
triggering the metabolic syndrome than the quantity of the fat per se. A direct relationship is
accepted between abdominal/visceral fat accumulation—apple-shaped obesity—and the
emergence and development of the metabolic syndrome or abdominal and pelvic cancers.
Unbalanced synthesis of pro- and anti-inflammatory adipocytokines in visceral obesity
contributes to the development of many features of the metabolic syndrome which cumulates
the factors that increase the risk for ischemic heart disease and cerebral stroke: apple-shaped
fat deposition, impaired glucose metabolism, dyslipidemia, and high blood pressure [8–10].
Pear-shaped obesity—i.e., subcutaneous fat accumulation—has a minimal risk for the devel-
opment of such pathologies even at the same BMI greater than 30 kg/m2 [11–13].
Hypoxia is one of the mechanisms responsible for the development of the metabolic changes
and the pro-inflammatory milieu of white adipose tissue in obesity [3].
Tissue partial O2 pressure (pO2) reflects the balance between O2 delivery and consumption,
and continuous, chronic low O2 tension occurs as a tissue inability to provide adequate
compensatory vascular supply [3, 14, 15]. Obviously, adipose tissue hypoxia has a polymorphic
feature since it depends on the adipose tissue blood flow regulation, different between the
adipose phenotype WAT or BAT, the adipose fat pad localization, subcutaneous or visceral,
and the delay of time between the onset of hypoxia and its quantification.
In healthy lean young adult, the pO2 in adipose tissue is considered 55–60 mm Hg [14, 16]
similar to the general tissue oxygenation [4], but important differences were reported in obese
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subjects. Oxygen supply was found markedly lower (44.7 mm Hg) in obese subjects in fasting
and postprandial status than in lean subjects (55.4 mmHg) [14, 17], but Goossens et al. [18]
found that in WAT of obese subjects the pO2 was even higher (67.4 mmHg) than lean
(46.8 mmHg). Of note, the pO2 is not in a direct relation with the surface of the vascular network
in the adipose pad. Capillary density for both subcutaneous and visceral depots is lower in
obese human than in lean, but in lean subjects, the density is greater in visceral location [14,
19]. Even if BAT adipose tissue is more vascularized than WAT, it was indicated that obesity
also causes BAT hypoxia, the same response being noted in multilocular adipocytes that
became larger in obese animals [20]. Interestingly, BAT hypoxia seems to be temperature-
dependent. Xue et al. proved that there is no hypoxia in mice housed at 30°C, but it appears
in animals living at 4°C [21].
Adipose tissue is one of the most plastic organs in adults gifted with the ability of a continuous
remodeling—extends or regresses depending on nutrient intake. The plasticity of any tissue
is due to its capacity of extending vasculature which requires the cross talk between adipocytes
and stromal and endothelial cells in the case of adipose tissue.
There are several arguments in favor of this “hypoxia concept.” Normally, each adipocyte is
surrounded by capillaries, and it is widely accepted that WAT is poorly oxygenated in obese
individuals because adipocytes may be up to 200 μm, so larger than the normal diffusion
distance of oxygen within tissues. As adipose tissue mass rapidly increases, clusters of
unilocular adipocyte distance from the vessels and pockets of hypoxia are generated [22].
Another cause presumed for adipose tissue hypoxia is the loss of endothelial cells usually
associated with the damage of parenchymal cells in other tissues. Recently, the interest in
brown adipose tissue (BAT) increased, and studies have indicated that obesity determines also
BAT hypoxia and the loss of its thermogenic capacity [20].
Chronic adipose tissue hypoxia has been suggested to be part of the pathogenesis of adipocyte
dysfunction [14, 23, 24]. Local hypoxia triggers the generation of reactive oxygen species (ROS)
and endoplasmic reticulum (ER) stress [25] and initiates the inflammatory response able to
regulate the balance between angiogenic factors and inhibitors in order to stimulate angio-
genesis and increase blood flow. The paucity of endothelial barrier is associated with the release
of profibrogenic and pro-inflammatory cytokines and an augmented influx of inflammatory
cells [26]. There is considerable evidence that obese adipose tissue is markedly infiltrated with
macrophages which participate in the inflammatory pathways and are very important in
adipose tissue remodeling, macrophage infiltration being signalized by lipid-overloaded
adipocytes necrosis. Numerous reports emphasized that visceral adipose tissue in obese
individuals is more fibrotic than that of lean subjects [27–29].
Normally, BAT and WAT produce various pro-angiogenic factors and cytokines able to induce
remodeling of the vasculature, and as a response to hypoxia, an unbalanced production of
these multiple bioactive pro-angiogenic and antiapoptotic growth factors synthesized by the
adipose stromal cells may occur. Local hypoxia in obese is the underlying cause of an increase
of macrophage cell number accompanied by the state of chronic inflammation and impaired
adipokine secretion. Hypoxia promotes the delivery of many adipocytokines related to
inflammation and tissue remodeling needed for angiogenesis to the ischemic tissue, such as
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macrophage migration inhibitory factor (MIF), granulocyte-macrophage colony-stimulating
factor (GM-CSF), matrix metalloproteinases MMP-2 and MMP-9, transforming growth factor
(TGF)-β, vascular endothelial growth factor (VEGF), interleukins (IL-1, IL-6, IL-10), tumor
necrosis factor (TNF)-α, angiopoietin-like (Angptl)-4, and leptin [4, 15, 22, 30–32].
This chapter summarizes the potential links between hypoxia, inflammation, adipocyte
hypertrophy, and macrophage infiltration of adipose tissue and the effects of inflammatory
mediators on its remodeling.
2. Essentials of adipose organ structure and functions
The adult adipose organ is composed by two types of adipose depots divided into adipose
lobules of (i) unilocular adipose tissue (WAT—white adipose tissue) composed of unilocular
cells and (ii) brown adipose tissue (BAT), formed by multilocular adipocytes (Figure 1a and b).
Figure 1. (a) Human adult subcutaneous WAT (hematoxylin and eosin staining, ob. ×40) and (b) human newborn vis-
ceral adipose depot with unilocular WAT and multilocular BAT adipocytes (hematoxylin and eosin staining, ob. ×20).
Both types of cells organized into adipose lobules are sustained by the stromo-vascular fraction
well vascularized and innervated [11, 33]. Anatomically, WAT depots are located primarily in
two major areas—subcutaneous/peripheral and visceral/central, which differ in the composi-
tion of the stromo-vascular fraction [34, 35]. Although at a first view the adipose tissue looks
quite simple, a deeper molecular analysis revealed a high heterogeneity of cells. With respect
to adipose cells, recent research identified both in rodent and men, the third type of adipocytes
with common features of WAT and BAT adipocytes named “brite” or “beige” cells.
BAT, so named because of its yellow-brown color in vivo due to a very rich vascularization, is
distinguishable morphologically from WAT by its cytoplasmic multiple droplets of stored
triglycerides, while WAT contains a single large droplet. The multilocular cells are rich in
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mitochondria containing the uncoupling protein (UCP)1 which is uniquely present in BAT and
therefore considered a marker for it (Figure 2).
Figure 2. Newborn human brown adipocytes labeled with UCP1 (IHC, ob. ×40).
In humans, two types of BAT are present: (i) the classical (or constitutive BAT—cBAT) that is
fully developed at birth and then reduced to remain in human adult only in a symmetrical
cervical position and around the clavicles as very recently localized by PET/CT scanning, and
the second type of brown adipocytes named “beige” or “brite” (brown in white), inducible or
recruitable BAT (rBAT). This is composed of isolated brown multilocular cells resident between
white cells mainly in subcutaneous depots [36, 37]. WAT is recognized as the site of fat storage,
while BAT acts, as in rodents, as a heat-generating tissue through uncoupled oxidative
phosphorylation which involves the action of UCP1 [38].
The functional complexity of adipose tissue is also due to the heterogeneity of cell phenotypes
located in the non-adipocitary stromo-vascular fraction that includes undifferentiated or
mesenchymal cells, preadipocytes, fibroblasts, and inflammatory cells (macrophages, lym-
phocytes, and mast cells). These cells are surrounded by a very complex network of vessels
and nerves. The vascular network is more developed and branched in BAT than in WAT [39].
Normal metabolic functions and their imbalance involve a cross talk between adipocytes and
the cells from the stromo-vascular fraction mediated by the components of adipose tissue
extracellular matrix (ECM).
WAT secretoma. The discovery of leptin by Friedman in 1994 initiated the recognition of white
adipocytes as major endocrine cells that secrete numerous bioactive molecules: lipids (such as
free fatty acids mobilized in lipolysis, prostaglandins, and endocannabinoids) and proteins
(termed “adipokines” or “adipocytokines” with metabolic and pro-/anti-inflammatory
functions) [40]. Several adipocytokines are listed in Table 1. Impaired production of adipokines
is associated with the pathogenesis of obesity-related disorders—type 2 diabetes mellitus,
metabolic syndrome, cardiovascular diseases, and certain types of cancer [2, 41–44]. Generally,
blood adipocytokine levels rise with the increase of fat mass except for adiponectin and
omentin levels which are reported to be lower in obese and overweight subjects [31, 45, 46].




Leptin Feeding behavior, fat mass, pro-angiogenic
Adiponectin Insulin sensitivity, anti-inflammatory, pro-angiogenic
Resistin Insulin resistance, pro-inflammatory, antiangiogenic
Visfatin (pre-B-cell colony-enhancing factor, PBEF) Insulin resistance, pro-inflammatory
Vaspin (visceral adipose tissue-derived serpin) Insulin resistance
Omentin Insulin resistance
Retinol-binding protein (RBP)-4 Insulin resistance
Serum amyloid A Insulin resistance, pro-inflammatory
Cholesteryl ester transfer protein (CETP) Lipid metabolism
Lipoprotein lipase (LPL) Lipid metabolism
Adipocyte fatty acid-binding protein (A-FABP)-4 Lipid metabolism
Perilipin Lipid metabolism
Apelin Vasodilatation, pro-angiogenic
Angiotensinogen Regulation of blood pressure
Angiotensin II Regulation of blood pressure
Adipsin (adipocyte trypsin/complement factor D) Lipid and glucose metabolism, inflammation
Tumor necrosis factor (TNF)-α Pro-inflammatory
Interleukin 6 (IL-6) Pro-inflammatory
C-reactive protein (CRP) Pro-inflammatory
Plasminogen activator inhibitor (PAI)-1 Fibrinolysis, pro-angiogenic
Monocyte chemoattractant protein (MCP)-1 Macrophage activation
Intercellular adhesion molecule (ICAM)-1 Macrophage activation
Fibroblast growth factor (FGF)-2 Pro-angiogenic
Hepatocyte growth factor (HGF) Pro-angiogenic
Platelet-derived growth factor (PDGF) Pro-angiogenic
Vascular endothelial growth factor (VEGF) Pro-angiogenic
Transforming growth factor (TGF)-β Inflammation, fibrosis
Matrix metalloproteinases (MMPs) Pro- and antiangiogenic, ECM remodeling
Tissue inhibitor of metalloproteinases (TIMPs) Antiangiogenic, ECM remosdeling
Table 1. Adipocytokines and their main biological effects (adapted with permission from [31]).
Leptin and adiponectin are the most important hormones secreted by white adipocytes with
multiple metabolic roles (regulating appetite and energy balance, insulin sensitivity) but also
encompass angiogenic and anti-inflammatory actions [2, 4]. Leptin increases the vascular
permeability in adipose tissue and influences microvessels density [47].
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Adiponectin is regarded as a link between obesity and related metabolic disorders because it
improves glucose and lipid metabolism and prevents inflammation [15]. There are many other
members of the “adipokinome” involved in the inflammatory response: tumor necrosis factor
(TNF)-α, interleukins (IL-6, IL-8, IL-10), monocyte chemoattractant protein (MCP)-1, and
macrophage migration inhibitory factor (MIF) [4, 15, 22]. Besides the adipocytes, many other
cells from the stromo-vascular fraction secrete inflammatory cytokines and chemokines in
response to adipocyte hypertrophy or hypoxic conditions. Other adipokines related to
inflammation include several crucial angiogenic factors, such as vascular endothelial growth
factor (VEGF), hepatocyte growth factor (HGF)-1, angiopoetin-2, nerve growth factor (NGF),
plasminogen activator inhibitor (PAI)-1, apelin, and adipsin [4, 30–32]. The release of numerous
inflammatory adipocytokines is markedly increased in obesity-related diseases. Subcutaneous
and visceral adipose tissue display differences in their adipokinome. Even if the results of in
vitro and in vivo studies are controversial, it can be assumed, for example, that leptin and
adiponectin are mainly produced in vivo by the subcutaneous adipocytes, while others
(angiotensinogen, A-fatty acid-binding protein (FABP)-4, IL-6) are secreted at higher levels in
visceral adipose tissue [48–51].
3. Adipose tissue dysfunction and hypoxia
Adipocyte capacity of synthesis corroborated with the clinical observation that a proportion
of obese individuals seem to be protected against metabolic syndrome [52] had highlighted
the role of adipose tissue dysfunction in obesity. Obesity is so long considered a genetic
predisposition that promotes the excess of energy intake or the scarce energy expenditure.
In humans, the adipose tissue from the two main locations (subcutaneous and visceral) shows
anatomical and functional differences (in contrast to subcutaneous adipose tissue, abdominal
depots drain directly onto the portal circulation [31]) and different gene expressions.
Oxygen is a main nutritional factor without which oxidation of nutrients in aerobic tissues
cannot take place. The decrease of oxygen level in various tissues can occur even if the total
amount provided to the organism is not reduced [20]. Evinced hypoxia that follows low oxygen
tension has numerous implications for cellular metabolism and transcriptional program [27].
Recent research suggests that adipose tissue hypoxia occurs in obese mice and even in human
subjects. In obese rodents the existence of hypoxia was demonstrated by qualitative reaction
(using hypoxic cell markers, such as pimonidazole—PIMO) or quantitative technique using
needle-type oxygen sensors [3, 15, 22, 23]. In human obese subjects, the results are more
controversial since normoxia and even hyperoxia have been reported in various experiments
[18, 20, 53].
Chronic hypoxia has been suggested to be part of the pathogenic pathways leading to adipose
tissue dysfunction [14, 23, 24].
Local hypoxia triggers the main alterations defining the adipose tissue dysfunction: generation
of ROS and oxidative stress [54], ER stress [25], adipocyte death [55], inhibition of adiponectin
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expression [55, 56], and leptin hyperproduction [57] and initiates the inflammatory response
able to regulate the balance between angiogenic and inhibitor factors in order to stimulate
angiogenesis and increase blood flow.
More causes of adipose tissue hypoxia are discussed, this concept being related to the histo-
logical changes of the adipose obese tissue—hyperplasia and adipocyte hypertrophy. Reduc-
tion of blood supply in adipose pads is a common mechanism of tissue hypoxia. Reduced
adipose tissue blood flow in obese rats and humans was reported many years ago (Larsen et
al, 1966, West et al., 1987 cited by [26]), being associated with insulin resistance in obese
individuals [17, 18]. Adipose tissue angiogenesis is insufficient to maintain normoxia in the
growing number of fat-storing cells in adipose depots as they are in obesity. Histological
analysis has demonstrated a scarce capillary network in abdominal subcutaneous depots in
obese subjects compared to the leans [14, 18].
A second cause is related to the increased size of adipocytes—hypertrophy—reaching in obese
subjects a diameter larger than 150–200 μm [45]. This exceeds the normal capacity of oxygen
diffusion through the tissue (100–200 μm), and oxygenation of adipose tissue will be compro-
mised [58].
Hypoxia-inducible factor (HIF)-1 is the key transcriptional factor involved in response to
hypoxia, which moves into the nucleus and binds to hypoxia-response elements from a myriad
of target genes to initiate their transcription [3]. Both murine and human adipocytes exhibit
extensive functional changes in culture in response to HIF-1, which alters the expression of up
to 1300 genes [59]. These include genes encoding key adipokines, such as leptin, apelin,
visfatin, TNF-α, IL-1, IL-6, VEGF, angiopoietin-like protein (Angptl)-4, MIF, PAI-1, and matrix
metalloproteinases 2 and 9 (MMP-2, MMP-9), which are upregulated, and adiponectin,
peroxisome proliferator-activated receptor (PPAR)-γ which is downregulated [3, 20, 55, 60, 61].
Hypoxia alters genes encoding key proteins for metabolic processes: glucose uptake, glycol-
ysis, oxidative metabolism, lipolysis, and lipogenesis. Glucose uptake into adipocytes is
stimulated by hypoxia because the expression of GLUT transporters is upregulated [20, 55,
62]. A switch from aerobic to anaerobic metabolism in hypoxic adipocytes is sustained by the
increased activity of some glycolytic enzymes (e.g., phosphofructokinase [63]) and a net lactate
release. Many studies focused on hypoxia-induced derangements of lipid metabolism
reporting an increased lipolysis rather than unchanged but reduced lipogenesis in hypoxic
adipocytes [64–66].
It seems that various degrees of adipose tissue hypoxia have different metabolic effects, and it
is supposed also that subcutaneous and visceral adipocytes respond differently to factors that
mediate tissue hypoxia. A recent study demonstrated that hypercaloric diet induces more
severe hypoxia in mesenteric adipose tissue of mice than in the subcutaneous one [67].
Another direct effect of hypoxia is induction of insulin resistance via the upregulation of certain
adipokines, the impairment of insulin-signaling pathway being a key change for white
adipocyte dysfunction in obese subjects [3, 4].
Adipose tissue is one of the most plastic entities of an organism in terms of growth in the
childhood and even in the adulthood in normal and pathological conditions, responding
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rapidly and dynamically to nutrient excess or starvation. Nor normal or pathological tissue,
therefore nor the adipose tissue, is able to grow, develop, and function in the absence of an
appropriate vascular network. Therefore, the hypoxia-induced expression of VEGF, the main
angiogenic factor, and of certain adipokines, such as angiopoietin-2, Angptl-4, and leptin,
sustains the stimulation of angiogenesis in obese adipose tissue [68–70]. Experimental data
emphasize the induction of a pro-fibrotic switch of the transcriptional program in hypoxic
adipocytes, fibrosis being another feature of adipose tissue dysfunction in obesity [29, 71].
Preadipocytes, pro-inflammatory cells, and fibroblasts from WAT as well as adipocytes
respond to hypoxic conditions, favoring cellular events that lead to inflammation and fibrosis.
Biostatistical analysis of WAT transcriptome had demonstrated a positive correlation between
fat mass, degree of inflammation, and synthesis of ECM in obesity complications [72].
4. WAT hypoxia: a link between obesity and inflammation
The necessary link between abdominal (visceral or central) obesity and the development of
type 2 diabetes and metabolic syndrome (which includes atherosclerosis, hypertension, and
hyperlipidemia) due to the expanding fat mass and adipose tissue dysfunction was first
demonstrated by Spiegelman’s group [73, 74]. The mild inflammation status of the adipose
tissue in obese subjects is induced by the peculiar role occupied by TNF-α, a 26 kDa trans-
membrane protein secreted as a cytokine and acting as an endotoxin-induced factor causing
necrosis of tumors in vitro and cachexia in vivo, so naturally linked to the energy homeostasis
[1]. They discovered that TNF-α is an active biofactor secreted by adipocytes and stromo-
vascular cells positively correlated with obesity and insulin resistance.
Many signaling pathways have been proposed to be involved in the pathogenesis of obesity-
associated inflammation called also “metaflammation” [75] such as (i) activation of toll-like
receptor 4 (TLR4) by free fatty acids released after lipolysis [76], (ii) activation of protein kinase
C (PKC) by diacylglicerol and ceramide [77]), (iii) induction of ER stress [25, 78] and oxidative
stress [79], and (iv) adipocyte death [39]. Recent research data suggest that adipose tissue
hypoxia is one of the first pathophysiological changes and was placed as a missing link between
obesity and low-grade inflammation [61, 80].
Clinical and physiological data argue that in the whole organism the oxygen level is not the
same in all the tissues nor constant for the same tissue and an isolate organ or tissue may lack
oxygen even if the total supply is not compromised. This seems to be the case of the hypoxia
inside the WAT human depots, the expanding adipose lobules or hypertrophic adipocytes
resting isolated in pockets of tissue that lack the vascular supply, while other areas could be
in normoxia or even hyperoxia [20]. The lack of oxygen perfusion for the hypertrophic
adipocytes made them necrotic and finally they died. Dead adipocytes and free lipid droplets
liberatedly act as recruitment factors for macrophages [39]. Besides adipocytes, preadipocytes
and macrophages (the main players in WAT inflammatory response stimulating the inflam-
matory state in adipose tissue by the release of pro-inflammatory cytokines, such as TNF-α
and interleukins) also respond to hypoxia. For such controversial results regarding the hypoxia
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in human adipose tissue, one must consider the technique accuracy and the methodological
issues, minding that the same depot could be polarized toward hypoxic areas or inflamed and
hypervascularized nests. Such a clustered differentiation is not unique in the adipose tissue
since data demonstrated that in obese adipose tissue the switch from M2a macrophages
discriminative for lean mice to M1 inflammatory phenotype takes place in well-defined
spatiotemporal areas inside the same adipose depot [81].
In order to assess the involvement of TLR signaling in inflammation in obesity-related diseases,
we analyzed the expression of TLR-2, TLR-4, TNF-α, and CD-68 in subcutaneous and visceral
adipose depots from lean, obese, and obese diabetic subjects. We observed that both types of
depots showed an increased number of small- and medium-dilated vessels with many CD68-
positive cells [82]. In the peritoneal depots, we observed leukocyte margination with CD68-
positive cells, but we didn’t notice the presence of macrophages crowns in none of the samples
analyzed, as Cinti and coworkers found in adipose tissue with hypertrophic cells [39]. Data
obtained proved that same cells from the visceral adipose depots of obese and obese-diabetic
patients, mainly macrophages, intravascular leukocytes, and endothelial cells, showed a
positive reaction for both TLR-4 and TNF-α [82], proving that TLR4 activation contributes to
the inflammatory process in obesity and the onset of the metabolic syndrome (Figure 3).
Figure 3. Immunostaining for CD68, TLR-4, and TNF-α of visceral obese adipose depots. (a) CD68-positive leukocytes
between adipocytes (ob. ×40) in adipose peritoneal depots, (b) TLR-4-positive leukocytes and endothelial cells
(ob. ×40), (c) intense-positive TNF-α reaction in visceral depots (ob. ×40).
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Summarizing the data linking the cellular and molecular alterations of the adipose tissue in
obesity to the adipose tissue dysfunction, among the three events highlighted—oxidative
stress, ER stress, and local hypoxia—hypoxia might be the first in a logical chronologically
order, since it promotes oxidative and ER stress. In obesity, quick changes from normoxia/
hyperoxia to hypoxia would be needed in order to induce oxidative stress [16]. Adipose tissue
hypoxia induces inflammation through activation of two main transcription factors, HIF-1α
and nuclear factor (NF)-KB, each of them activating transcription of a variety of genes encoding
angiogenic and/or pro-inflammatory adipocytokines [26, 83]. Available data demonstrate that
in rodent, HIF-1α upregulation starts in the first 1–3 days after the administration of a high-
fat diet, before inflammation and insulin resistance develop [15, 19, 84].
5. Hypoxia: a major trigger for adipose tissue remodeling
Adipose tissue hypoxia is a concept that can practically explain the main alterations defining
the adipose tissue dysfunction due to obesity: chronic inflammation, leptin expression,
adiponectin reduction, adipocyte death followed by the invasion of monocytes and activation
of macrophages, elevated lipolysis and adipocyte insulin resistance, and increased activity of
ROS [3, 15, 55]. This entire cellular and molecular imbalance is followed by a compulsory
adipose depot remodeling. The concept of remodeling of adipose tissue refers, as in all other
entities, to the turnover of the cells and of the ECM in response to the requirement for growth
and expansion of the adipose depots [85]. The molecules (cytokines, adipokines, growth
factors, and proteases) involved in adipose tissue remodeling are synthesized and act as a
permanent result of the cross talk between adipocytes and stromal cells.
5.1. Adipocyte death and inflammation
Adipocyte death is accepted as the main trigger for the adipose tissue remodeling [84], but the
cause of this event is not consensual: the adipocyte size or the hypoxic milieu. In mice a positive
robust correlation exists between adipocyte size and adipocyte death [39]. Consecutively
macrophages are accumulating in crown-like structures being a source of numerous pro-
inflammatory cytokines. A difference in the incidence of dead adipocytes was noted, the intra-
abdominal cells being more susceptible than those of the inguinal depots. The clearance of the
cellular detritus by the macrophages is the trigger for a homeostatic remodeling program that
will allow the further expansion of the adipose depots that include matrix remodeling and
vasculogenesis. Foci of adipocyte death are therefore areas where macrophages promote
obesity-associated inflammation [39]. Interestingly, adipocyte loss is associated with pheno-
typic changes in stromal monocytic-macrophage cells. In a chronologically sequence, after the
scavenging, the place occupied by the huge dead adipocytes was taken by small-size adipo-
cytes, and the former hypertrophic adipose tissue became hyperplasic (Faust et al., 1984 cited
by [84]). As a new study demonstrated that the macrophages are crowded in foci of hypoxic
tissue, a second theory emphasizes that adipocyte death is caused by the hypoxia and the
macrophages are trapped into the hypoxic areas by MIF [65, 86].
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5.2. Hypoxia underpins adipose tissue fibrosis
There are several recent studies involving fibrosis of adipose depots in installing hypoxia and
insulin resistance [27, 28, 87].
Scherer’s research group proposed that in adipose obese tissues hypoxia is the most important
driving force downstreaming the events associated with inflammation and fibrosis [27]. They
found that in adipose tissue from the transgenic mice HIF-1α-ΔODD, in which a dominant-
active deletion mutation of HIF-1α is overexpressed, fed with a hypercaloric diet, the tran-
scription factor HIF-1α failed to promote the pro-angiogenic program by targeting genes, such
as VEGF-A. Moreover, in these mice HIF-1α induces the fibrotic program by an increased
synthesis of fibrotic proteins, such as lysyl oxidase (LOX), type I and type III collagens, tissue
inhibitor of matrix metalloproteinases (TIMP)-1, and connective tissue growth factor (CTGF).
Histology performed with trichromic staining revealed thick fibrotic streaks composed of type
I collagen fibers, similar results being reported also for the adipose pads from obese human
subjects [88].
LOX is a known target gene of HIF-1α, and in adipose tissue of ob/ob transgenic mouse, LOX
is found in increased level compared to wild type [27]. LOX cross-links elastin and collagens
in ECM and creates ECM-resistant bands of fibrosis. In adipose tissue of ob/ob mouse, these
collagen bundle “streaks” are found outside the “crown-like” structures previously described
[27, 39, 84]. The conclusion derived was that collagen synthesis and deposition could be
anterior to the accumulation of macrophages surrounding the adipose cells because hypoxia-
induced fibrotic program develops shortly after the high-fat diet is established [27]. So adipose
tissue fibrosis is not necessarily induced by inflammation but could be rather an upstream
phenomenon through the synthesis of HIF-1α and LOX.
From a different point of view, like in other tissues, adipose tissue fibrosis develops as a result
of a persistent inflammation and a failure of the normal tissue repair with restitutio ad integrum.
Interestingly, fibrosis of adipose depots in obesity seems to display an otherwise intensity as
the inflammation and hypoxia, those visceral seeming to be not only less fibrotic than those
peripheral but also with a different distribution of collagen fibers, especially pericellular or
intraparenchymatous [28]. As the visceral depots are more inflamed than the subcutaneous
depots as we showed [88], this observation contradicts the accepted biological sequence that
fibrosis develops as a result of an excessive and altered ECM synthesis and storage by resident
cells activated in an inflammatory environment. This abnormal amount of fibrotic matrix in
the subcutaneous adipose tissue could be explained if we keep in mind the histology of the
host tissue where the adipose depots expand (the subcutaneous adipose tissue develops
toward a much more dense tissue than the visceral one). In obese subjects fibrosis accumulates
in pericellular areas—lining each adipose cell or a group of cells (interstitial fibrosis) and
around the vessels (Figure 4).
Collagen phenotypes are also different, types I, III, and VI being present in pericellular position
but only I and III form thick bundles appearing as interlobular septa surrounding more cells
[28]. In visceral (omental) depots, the accumulation of fibers in pericellular position is associ-
ated with small adipocyte size and a lowest quantity of circulating triglycerides, proving that
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the subjects with smaller adipocytes have a less adverse metabolic profile [27, 89], so fibrosis
may act as a protective reaction. In the adipose depots, the significance of type VI collagen
seems to be peculiar, since its appearance changes dramatically through adipogenesis [90].
Transgenic mouse col 6KO ob/ob shows reduced necrotic cell death and consumes only a half
of the amount of food that ob/ob strain [91] and type VI collagen levels correlate with hyper-
glycemia and insulin resistance [87, 92]. Obese humans expressed higher levels of type VI
collagen and macrophage markers [92].
Figure 4. Pericellular and interstitial fibrosis in a visceral adipose depot from an adult obese subject (ob. ×20).
5.3. Hypoxia-induced angiogenesis in white adipose tissue
Being a compulsory condition for the expansion of any tissue, angiogenesis is a very limited
process in normal adulthood (in endometrial cyclic physiology or wound healing), and the
endothelial cells of the adult capillary network are in a relatively quiescent state.
In adipose tissue, angiogenesis is a very complex phenomenon regulated by a lot of molecules
(hormones, cytokines, and growth factors) secreted by the stromo-vascular cells, including
endothelial cells, and also by the adipocytes and preadipocytes [93, 94].
During adipose depot development, adipogenesis and vasculogenesis are temporally and
spatially dependent, and in an adipose depot, the vascular network seems to act as a self-stop
for the adipose expansion, since the inhibition of angiogenesis reduces the adipose tissue mass
[95, 96].
In hypoxia induced by a high caloric intake, the vascular network does not progress uniformly
between depots, due to the differences between the initial degree of vascularization and the
rate/capacity of neovascularization during adipose tissue expansion. Hypoxia is more severe
in mesenteric visceral depots than in subcutaneous [67], and at the same time, human visceral
depots reveal a greater capillary density and angiogenic capacity than the subcutaneous
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adipose tissue [97, 98]. In their study using CD31+/CD34+ immunolabeling, Villaret and
coworkers revealed that in obesity the capillary network is more developed and endothelial
cell number is greater in visceral than in subcutaneous adipose depots, so increased hypoxia
of visceral adipose tissue is not necessarily a consequence of capillary rarefaction [98]. The pro-
angiogenic and pro-inflammatory phenotype of visceral adipose tissue could be related to
endothelial cell senescence proved by an altered expression of some senescence markers such
as IGFBP3, γH2AX, and SIRT1. They postulated at least two main causes for endothelial cell
senescence in visceral adipose tissue: increased cell replication and oxidative stress [98].
Hyperplasia of obese visceral adipose tissue is responsible for an increased secretion of VEGF-
A2 that stimulates endothelial cell proliferation.
The compensatory angiogenesis could prevent the metabolic disturbances induced by the
hypoxia. It seems that not in all conditions the expansion of adipose tissue is associated with
inflammation if an appropriate capillary bed is developed. If this condition is satisfied, the
obese subjects are termed “metabolically healthy obese” because they may expand their
adipocyte depots without inflammation consequences. This kind of expansion is associated
with an enlargement of a given fat pad through recruitment of new adipocytes along with an
adequate development of the vasculature, minimal associated fibrosis, and the lack of hypoxia
and inflammation [83, 99].
The effects of hypoxia for obese humans have been recently disputed, the reactions triggered
by the oxygen deprivation being a matter of severity, duration, and environment, since results
between in vitro experiments, cell cultures under acute hypoxia, animal models, and human
obese subjects are different. In recent studies, opposite data are reported by Goossens’s research
group. Their experiments revealed an increased pO2 in obese insulin-resistant subjects and a
positive correlation between pO2 and gene expression for pro-inflammatory markers and an
inverse association between pO2 and peripheral insulin sensitivity [18]. In another experiment,
after exposing mice at normoxia and hypoxia for the same duration of time, the authors
reported a decrease in adipocyte size, macrophages infiltration, and inflammatory cell genes
in adipose tissue from hypoxic animals [100]. The same results were reported for obese men
exposed for 10 nights to hypoxia consecutively followed by increased insulin sensitivity [101].
Moreover, it was presumed that the obstructive sleep apnea could be a protective mechanism
to maintain energy homeostasis in obese subjects [102, 103]. Angiogenesis in hypoxic tissues
is controlled by HIF-1α, so-called the master regulatory of cellular and tissue response to
hypoxic stress. In adipose hypoxic tissue, HIF-1 induces angiogenesis by upregulating VEGF
gene. VEGF-A is the only endothelial growth factor that stimulates ECM degradation,
proliferation, migration, and tube formation of endothelial cells [104]. VEGF secretion is
regulated also by insulin stimulation, growth factor, and cytokines, such as PDGF, EGF, TNF-
α, TGF-α, and IL-1β [99, 104].
As we showed in a previous study, VEGF immunohistochemical expression was higher in the
adipose tissue of obese and obese-diabetic patients, especially in peritoneal depots. In normal
weight subjects, both peripheral and central depots were VEGF negative [88].
It was demonstrated that an overexpression of VEGF in transgenic animals increased the
vascularization and reversed the metabolic dysfunctions induced by a hypercaloric diet [80].
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Recently, it had been claimed that the mechanism of VEGF promoting angiogenesis in adipose
tissue is controlled by HIF-1β, while HIF-1α seems to regulate vascularization in BAT but not
in WAT and additionally to promote WAT inflammation [105].
Adipokines, such as leptin and adiponectin, have also angiogenic properties that are stimu-
lated in metabolically challenging conditions: leptin stimulates the angiogenic program
upregulating VEGF expression, increases the vascular permeability by the formation of
fenestrations in endothelial cells, and influences microvessel density [106]. For adiponectin,
the results are conflicting: one supposed to be antiangiogenic because it inhibits endothelial
cell migration and proliferation in vitro and neoangiogenesis in vivo [107] and others pro-
angiogenic [99, 108].
6. Hypoxia: a trigger for BAT whitening and WAT browning
BAT presence has been reported once for small rodents and newborns, but recently, evidence
for metabolically active BAT in adult humans has been reported [109]. BAT activation under
β-adrenergic signaling is important for heat generation through uncoupled oxidative phos-
phorylation as a result of activation of non-shivering thermogenesis [110]. For this function,
an important blood supply is required to provide the amount of oxygen and nutrients, and
therefore BAT is much more vascularized than WAT. In relation to energy balance, an inverse
relationship is accepted between BMI and age, BAT being less active in older subjects and in
obese [111, 112]. Recent experiments highlighted the importance of hypoxia in BAT dysfunc-
tion too, the lack of an adequate BAT vascularization being involved in the overall dysfunction
of the adipose organ in obesity [20]. BAT activity reduces the development of metabolic
syndrome, and its activation increases insulin sensitivity and contributes to glucose homeo-
stasis [113]. Having a high oxidative capacity, it is presumed that BAT is a contributor to
systemic metabolic homeostasis, and this function was impaired in obesity, as demonstrated
in the experiment performed by Shimizu and coworkers [114]. They proved in mice that obesity
affects the density of the capillary network in BAT much more than in WAT and induced
hypoxia in this organ. This elegant experiment shows in a very credible manner that the
transition of phenotype from brown to white adipocytes is induced by the diminution of
vascularization, a reverse mechanism of BAT differentiation observed in fetal development
when the appearance of multilocularity is anticipated by the branching of the capillary loops
(personal unpublished data). This vascular dysfunction is followed by the “whitening of the
brown fat” (diminished β-adrenergic signaling, the appearance of enlarged lipid droplets in
the cells and loss of mitochondria) and can impact obesity and obesity-related diseases [115].
HIF-1α increased level and suppression of UCP1 gene were observed in hypoxic BAT [114].
The same influences that hypoxia exerts on gene expression in WAT have been reported also
for BAT, such as increased expression of leptin, VEGF, IL-6, and GLUT1. Due to loss of
mitochondria, high glucose uptake will be accompanied by the same switch to anaerobic
glycolysis as in WAT. Besides triggering inflammation in macrophages, lactate is supposed to
be involved also in “browning of the white fat,” recent experimental data proving that in vitro
lactate induces the expression of genes encoding UCP1 and proteins involved in mitochondrial
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oxidation in mice and human white adipocytes [116]. Same authors demonstrated that lactate
also controls the browning process in vivo because it regulates Ucp1 expression in a PPAR-δ-
dependent manner, the combination of lactate and PPAR-δ ligand rosiglitazone constituting a
strong inducer of an increased expression of some mitochondrial oxidation markers in mice
white adipose depots [116]. Based on this observation, one can assume that lactate could be
responsible for the recruitment of “brite” cells. In light of these results, the recruitment and
activation of BAT are regarded as a potential new target for strategies to counteract obesity-
induced changes.
In conclusion, hypoxia could be regarded as the leading cause of adipose tissue remodeling
rather than as a consequence of the functional changes in the adipose organ. Due to the
interplay between hypoxia, inflammation, and angiogenesis, targeting hypoxia pathways
could be a valuable therapeutic approach to reduce the clinical consequences of the metabolic
syndrome.
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